These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 25818577)

  • 21. Attenuated Actinobacillus pleuropneumoniae double-deletion mutant S-8∆clpP/apxIIC confers protection against homologous or heterologous strain challenge.
    Xie F; Li G; Zhou L; Zhang Y; Cui N; Liu S; Wang C
    BMC Vet Res; 2017 Jan; 13(1):14. PubMed ID: 28061786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk assessment of transmission of capsule-deficient, recombinant Actinobacillus pleuropneumoniae.
    Inzana TJ; Glindemann G; Fenwick B; Longstreth J; Ward D
    Vet Microbiol; 2004 Nov; 104(1-2):63-71. PubMed ID: 15530740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Construction of an Actinobacillus pleuropneumoniae serotype 2 prototype live negative-marker vaccine.
    Tonpitak W; Baltes N; Hennig-Pauka I; Gerlach GF
    Infect Immun; 2002 Dec; 70(12):7120-5. PubMed ID: 12438394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Both ApxI and ApxII of Actinobacillus pleuropneumoniae serotype 1 are necessary for full virulence.
    Boekema BK; Kamp EM; Smits MA; Smith HE; Stockhofe-Zurwieden N
    Vet Microbiol; 2004 May; 100(1-2):17-23. PubMed ID: 15135509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Construction and characterization of Actinobacillus pleuropneumoniae serovar 7 live attenuated vaccine strain co-expressing ApxIA].
    Liu J; Chen Y; Hu L; Bei W; Chen H
    Sheng Wu Gong Cheng Xue Bao; 2010 Mar; 26(3):305-10. PubMed ID: 20518341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attenuation of Actinobacillus pleuropneumoniae by inactivation of aroQ.
    Ingham A; Zhang Y; Prideaux C
    Vet Microbiol; 2002 Jan; 84(3):263-73. PubMed ID: 11731178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral immunization against porcine pleuropneumonia using the cubic phase of monoolein and purified toxins of Actinobacillus pleuropneumoniae.
    Lopez-Bermudez J; Quintanar-Guerrero D; Lara Puente H; Tórtora Perez J; Suárez Güemez F; Ciprián Carrasco A; Mendoza Elvira S
    Vaccine; 2014 Nov; 32(50):6805-11. PubMed ID: 25446832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytoplasmic glycoengineering of Apx toxin fragments in the development of Actinobacillus pleuropneumoniae glycoconjugate vaccines.
    Passmore IJ; Andrejeva A; Wren BW; Cuccui J
    BMC Vet Res; 2019 Jan; 15(1):6. PubMed ID: 30606265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Actinobacillus pleuropneumoniae surface polysaccharides: their role in diagnosis and immunogenicity.
    Dubreuil JD; Jacques M; Mittal KR; Gottschalk M
    Anim Health Res Rev; 2000 Dec; 1(2):73-93. PubMed ID: 11708600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of protective immune responses against the challenge of Actinobacillus pleuropneumoniae by the oral administration of transgenic tobacco plant expressing ApxIIA toxin from the bacteria.
    Lee KY; Kim DH; Kang TJ; Kim J; Chung GH; Yoo HS; Arntzen CJ; Yang MS; Jang YS
    FEMS Immunol Med Microbiol; 2006 Dec; 48(3):381-9. PubMed ID: 17054716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimization of immune strategy for a construct of Salmonella-delivered ApxIA, ApxIIA, ApxIIIA and OmpA antigens of Actinobacillus pleuropneumoniae for prevention of porcine pleuropneumonia using a murine model.
    Hur J; Lee JH
    Vet Res Commun; 2014 Mar; 38(1):87-91. PubMed ID: 24307459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of antigen-specific immune responses by oral vaccination with Saccharomyces cerevisiae expressing Actinobacillus pleuropneumoniae ApxIIA.
    Shin SJ; Bae JL; Cho YW; Lee DY; Kim DH; Yang MS; Jang YS; Yoo HS
    FEMS Immunol Med Microbiol; 2005 Feb; 43(2):155-64. PubMed ID: 15681145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccination and protection of pigs against pleuropneumonia with a vaccine strain of Actinobacillus pleuropneumoniae produced by site-specific mutagenesis of the ApxII operon.
    Prideaux CT; Lenghaus C; Krywult J; Hodgson AL
    Infect Immun; 1999 Apr; 67(4):1962-6. PubMed ID: 10085043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of antigenic determinants in ApxIIA exotoxin capable of inducing protective immunity to Actinobacillus pleuropneumoniae challenge.
    Seo KW; Kim DH; Kim AH; Yoo HS; Lee KY; Jang YS
    Immunol Invest; 2011; 40(5):465-80. PubMed ID: 21425909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deletion of the znuA virulence factor attenuates Actinobacillus pleuropneumoniae and confers protection against homologous or heterologous strain challenge.
    Yuan F; Liao Y; You W; Liu Z; Tan Y; Zheng C; BinWang ; Zhou D; Tian Y; Bei W
    Vet Microbiol; 2014 Dec; 174(3-4):531-539. PubMed ID: 25465668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant ApxIV protein enhances protective efficacy against Actinobacillus pleuropneumoniae in mice and pigs.
    Wu HC; Yeh PH; Hsueh KJ; Yang WJ; Chu CY
    J Appl Microbiol; 2018 Jun; 124(6):1366-1376. PubMed ID: 29431246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of proteins of Propionibacterium acnes for use as vaccine candidates to prevent infection by the pig pathogen Actinobacillus pleuropneumoniae.
    Li L; Sun C; Yang F; Yang S; Feng X; Gu J; Han W; Langford PR; Lei L
    Vaccine; 2013 Oct; 31(45):5269-75. PubMed ID: 24051157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Induction of polyvalent immunity against Actinobacillus pleuropneumoniae in an experimental rat model].
    Herrera L; Montiel E; Rosales ME; Bárcenas G; Lara AV; Montaraz JA
    Rev Latinoam Microbiol; 1995; 37(2):147-52. PubMed ID: 8552874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and characterization of serovar-independent immunogens in Actinobacillus pleuropneumoniae.
    Antenucci F; Fougeroux C; Bossé JT; Magnowska Z; Roesch C; Langford P; Holst PJ; Bojesen AM
    Vet Res; 2017 Nov; 48(1):74. PubMed ID: 29122004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aerosol treatment of pigs with Actinobacillus pleuropneumoniae serotype 2: mucosal immunity and resistance against challenge.
    Loftager MK; Eriksen L; Nielsen R
    Adv Exp Med Biol; 1995; 371B():1611-4. PubMed ID: 7502867
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.